CIPO Patents = 1

EPO Patents = 5

Forward Citations = 43

Loading Chart...

3 inventors (with patents filed for the assignee):

Wataru Akahata (10 out of 22 patents)

Ryuji Ueno (9 out of 151 patents)

Jonathan F Smith (2 out of 2 patents)

10 patents: Sort by Forward Citations

1. 12280102 - Alphavirus replicon encoding chimeric SARS-CoV-2 receptor binding domains (2025-04-21),

2. 12227770 - Alphavirus replicon particle (2025-02-18),

3. 12134777 - Alphavirus replicon vector and immunotherapy by administering same (2024-11-05),

4. 10464986 - Virus like particle comprising PD-1 antigen or PD-1 ligand antigen (2019-11-05),

5. 10385101 - Virus like particle comprising modified envelope protein E3 (2019-08-20),

6. 10166281 - Method and composition for modulating immune response (2019-01-01),

7. 10098943 - Flavivirus virus like particle (2018-10-16),

8. 9969986 - Virus like particle comprising modified envelope protein E3 (2018-05-15),

9. 9637532 - Virus like particle comprising PD-1 antigen or PD-1 ligand antigen (2017-05-02),

10. 9249191 - Virus like particle composition (2016-02-02),

VLP Therapeutics, LLC is a biotechnology company focused on developing and commercializing novel vaccines and immunotherapeutics using virus-like particles (VLPs). VLPs are versatile platforms that can be engineered to target a variety of diseases including infectious diseases, cancer, and autoimmune disorders. The company's innovative approach has the potential to revolutionize the field of vaccination and immunotherapy.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

10 Patents

#321 in Wilmington, DE

#427 in Delaware

#28,955 in US

#54,268 in the World

Wilmington, DE, United States of America

Vlp Therapeutics, LLC

Forward Citations = 43

3 inventors:

Wataru Akahata (10 out of 22 patents)

Ryuji Ueno (9 out of 151 patents)

Jonathan F Smith (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

5 patents (EPO):

Please report any incorrect information to support@idiyas.com